Precision oncology should include prevention and early prostate cancer treatment

Greater personalisation along the whole continuum of care from prevention to management of advanced disease is the holy grail in prostate cancer, according to one of the invited speakers at the 2019 COSA ASM. Professor Stacy Loeb, a urologist from New York University, said most discussion about precision oncology was related to advanced disease and ...